AVEO
AVEO Pharmaceuticals, Inc.
AVEO
AVEO
Delisted
AVEO was delisted on the 19th of January, 2023.
57 hedge funds and large institutions have $218M invested in AVEO Pharmaceuticals, Inc. in 2017 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 18 increasing their positions, 12 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
50% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 12
16% more funds holding
Funds holding: 49 → 57 (+8)
Holders
57
Holding in Top 10
3
Calls
$6.61M
Puts
$1.51M
Top Buyers
| 1 | +$15.1M | |
| 2 | +$10.6M | |
| 3 | +$3.05M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.6M |
| 5 |
SIM
Spark Investment Management
New York
|
+$1.44M |
Top Sellers
| 1 | -$9.85M | |
| 2 | -$9.54M | |
| 3 | -$6.67M | |
| 4 |
Renaissance Technologies
New York
|
-$5.22M |
| 5 |
AC
Armistice Capital
New York
|
-$3.55M |